Drug discovery

Bacteria in Petri dishes
#Antibiotics #Antimicrobial resistance (AMR) #Drug discovery #Japan #UK

UK-Japan partnership to tackle antimicrobial resistance

Two experts in infectious disease have been selected to be policy fellows as part of a wider Japan-UK collaboration to tackle the growing crisis of antimicrobial resistance (AMR). AMR is a major threat to global health and was responsible for 1.27 million deaths in 2019 alone. Read More

#News

A team working in a laboratory
#AI / data analytics / healthtech / informatics #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Webinar

Connecting teams and designsets across the DMTA cycle

This paid-for advertorial by Cresset appeared in DDW Volume 25 – Issue 3, Summer 2024. Earlier this year, DDW hosted a webinar, ‘Enhancing collaboration in drug discovery – a biotech perspective’, supported by Cresset. The event emphasised the importance of creating a solid infrastructure within any discovery project to enable… Read More

#Exclusive Content

UK vector
#Brexit #Clinical trials #Drug discovery #Ireland #UK

Biogen’s vision for UK & Ireland  

DDW Editor Reece Armstrong speaks to Kylie Bromley, General Manager and Managing Director of Biogen UK & Ireland, about her career within the life sciences industry and the challenges of navigating a large pharma company within the UK and Ireland.   RA: Could you tell us about your career… Read More

#Exclusive Content

Mouse in drug discovery research
#Animal models #Drug discovery #Genetically engineered models (GEMs) #Humanisation #Humanised Immune System (HIS) #Mouse models

Elevating drug discovery through access to in vivo models

This paid-for advertorial by Taconic Biosciences appeared in DDW Volume 25 – Issue 3, Summer 2024. Harnessing the power of sophisticated GEMs and humanized mice is essential to moving research forward. In the dynamic landscape of drug discovery, the utilisation of high-quality animal models is paramount for success. Among these… Read More

#Exclusive Content

Protein
#Biopharma #Cryo-EM #Drug discovery #Molecular Biology #Protein degradation

How targeted protein degradation will live up to the hype 

Dr Benedict Cross, CTO, PhoreMost, explores the drug discovery potential that targeted protein degradation (TPD) offers.   The ubiquitin proteasome pathway (UPP) has been a subject of interest for therapeutic intervention since the first proteasome inhibitors to treat multiple myeloma were developed and approved in 2015. The… Read More

#Exclusive Content

RNA vaccine
#Drug discovery #mRNA #RNA Therapeutics #Vaccines

The evolution of the RNA therapeutics landscape 

Bruce Sullenger, PhD Founder and Scientific Advisor of Basking Biosciences, and Joseph W And Dorothy W Beard Distinguished Professor of Experimental Surgery and the Founding Director of the Translational Research Institute at Duke University, explores the rise of RNA therapeutics.   For decades, the life sciences community held the… Read More

#Exclusive Content

#Biotech #Cell analysis #Drug discovery #Flow Cytometry

Improving on current challenges in cell analysis 

Dr Lindsay Fraser, Chief Science and Operations Officer, and Dr Fernanda Masri, Chief Commercial and Innovation Officer, at Cytomos explore current advances in technology that are helping improve cell analysis within drug discovery.   The biopharma industry is under increasing pressure to bring novel therapies to market,… Read More

#Exclusive Content

#Biotech hubs #Drug discovery #Drug discovery hotspots #Life sciences #Precision medicine #UK

Whitepaper: Precision medicine and the role of ecosystems

A new whitepaper is now available to download for free from Bruntwood SciTech. This whitepaper, Fuelling the future: Precision medicine innovation and the role of ecosystems, examines how the future of drug discovery and precision medicine can be enhanced by life science ecosystems such as those created by the UK’s… Read More

#News

Whitepaper: Fuelling the future: Precision medicine innovation and the role of ecosystems
#Biotech hubs #Drug discovery #Drug discovery hotspots #Life sciences #Precision medicine #UK

Fuelling the future: Precision medicine innovation and the role of ecosystems

This whitepaper, Fuelling the future: Precision medicine innovation and the role of ecosystems, examines how the future of drug discovery and precision medicine can be enhanced by life science ecosystems such as those created by the UK’s leading property developer to the science and technology sectors, Bruntwood SciTech. In the whitepaper,… Read More

#Resources

ALS concept
#Amyotrophic lateral sclerosis (ALS) #Biomarkers #Drug discovery #Neuroscience #Partnership

How a new partnership aims to tackle ALS

DDW Editor Reece Armstrong speaks to Alessio Travaglia, PhD, Director, Translational Science, Neuroscience, Foundation for the National Institutes of Health (FNIH) about challenges in treating amyotrophic lateral sclerosis (ALS) and why a new public-private partnership launched by the FNIH is hoping to advance new drugs and diagnostics for the… Read More

#Exclusive Content

#Career #CRISPR #Drug discovery #Meet the Researcher #Milner Therapeutics Institute #University of Cambridge #Wet labs

Meet the researcher: Nicola McCarthy, Milner Therapeutics Institute

DDW’s Megan Thomas talks to Nicola McCarthy, Head of Research at the Milner Therapeutics Institute.  MT: Could you start by giving me your name, your job title and what you do?  NM: I’m Head of Research at the Milner Therapeutics Institute, which is part of the University of Cambridge, and… Read More

#Exclusive Content #Opinion

Polling station sign
#Association of the British Pharmaceutical Industry #Drug discovery #Medicines Discovery Catapult #UK #UK government

UK 2024 election: A vote for drug discovery

By DDW Editor Reece Armstrong The upcoming general election in the UK has placed the priorities of the country into the spotlight and the drug discovery sector should in no way be forgotten. Economic uncertainty, challenging global conditions and a healthcare system facing serious pressures, means that whatever government takes the… Read More

#Exclusive Content #Opinion

#Drug discovery #ELRIG #Events #The Protein Society

Partnership to advance protein sciences in drug discovery 

ELRIG UK has partnered with The Protein Society (TPS) to provide forums for the advancement of research into protein structure, function, design and applications.   The partners will collaborate to deliver a joint conference on ‘Protein Sciences in Drug Discovery’, bringing together their respective communities to focus on… Read More

#News

#Appointment #Career #Drug discovery #New appointment

Senior level moves within drug discovery

There have been a significant number of changes in c-level positions within the industry over the last two months. Dale Levitzke, Chief Executive Officer, and Curtis Nicholson, Director of Sales for Europe, Middle East, and Africa (EMEA), Sphere Fluidics: Levitzke brings over 25 years’ experience in… Read More

#News

Neuroscience concept
#Drug discovery #In Focus Report #Market reporting #Neuroscience

New eReport: Advances in neuroscience research

The global prevalence of dementia is approximately 24 million, and is predicted to double every 20 years until at least 2040. Currently, no medications can cure this, though 2024 has proved to be a poignant year of developments in neuroscience, especially considering the challenges faced in previous decades. This guide… Read More

#News